CONTI, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 8.774
EU - Europa 4.236
AS - Asia 4.021
SA - Sud America 638
AF - Africa 77
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 9
Totale 17.769
Nazione #
US - Stati Uniti d'America 8.542
SG - Singapore 1.549
CN - Cina 984
IT - Italia 854
DE - Germania 787
RU - Federazione Russa 630
HK - Hong Kong 510
BR - Brasile 506
VN - Vietnam 453
SE - Svezia 445
IE - Irlanda 361
GB - Regno Unito 297
UA - Ucraina 222
CA - Canada 169
AT - Austria 148
IN - India 128
FI - Finlandia 125
FR - Francia 93
TR - Turchia 84
DK - Danimarca 63
ID - Indonesia 61
AR - Argentina 52
KR - Corea 50
JP - Giappone 48
PL - Polonia 45
BD - Bangladesh 43
MX - Messico 38
BE - Belgio 37
ZA - Sudafrica 35
NL - Olanda 34
EC - Ecuador 25
ES - Italia 24
IQ - Iraq 21
CZ - Repubblica Ceca 15
EG - Egitto 15
VE - Venezuela 15
EU - Europa 13
IR - Iran 13
LT - Lituania 12
PK - Pakistan 12
AE - Emirati Arabi Uniti 10
CL - Cile 10
MA - Marocco 10
CO - Colombia 9
PE - Perù 8
CH - Svizzera 7
HU - Ungheria 7
PH - Filippine 7
SA - Arabia Saudita 7
AU - Australia 6
JM - Giamaica 6
RO - Romania 6
BO - Bolivia 5
AZ - Azerbaigian 4
BG - Bulgaria 4
DZ - Algeria 4
KE - Kenya 4
NI - Nicaragua 4
PT - Portogallo 4
PY - Paraguay 4
SN - Senegal 4
TT - Trinidad e Tobago 4
AL - Albania 3
HN - Honduras 3
IL - Israele 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LV - Lettonia 3
NO - Norvegia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
OM - Oman 3
UY - Uruguay 3
UZ - Uzbekistan 3
BH - Bahrain 2
ET - Etiopia 2
GA - Gabon 2
GT - Guatemala 2
JO - Giordania 2
MY - Malesia 2
PA - Panama 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
A1 - Anonimo 1
BS - Bahamas 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GR - Grecia 1
GY - Guiana 1
IS - Islanda 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
Totale 17.764
Città #
Ann Arbor 2.175
Singapore 959
Ashburn 750
Chandler 534
Woodbridge 523
Hong Kong 505
Frankfurt am Main 447
Wilmington 377
Dublin 349
Houston 338
Fairfield 298
Milan 298
Jacksonville 268
Dearborn 250
New York 224
Dallas 208
Santa Clara 170
Ho Chi Minh City 158
Beijing 154
Los Angeles 145
Seattle 142
Vienna 131
Princeton 130
Cambridge 109
Nanjing 95
Hanoi 84
Shanghai 82
The Dalles 79
Hefei 64
Buffalo 59
São Paulo 58
Boardman 55
Jakarta 51
Lachine 51
Guangzhou 48
Munich 46
Council Bluffs 45
Moscow 45
Helsinki 41
Chicago 38
London 38
Tokyo 38
Brussels 36
Lawrence 36
Rome 35
Warsaw 35
Denver 33
Nanchang 33
Orem 33
Seoul 31
Dong Ket 30
Ottawa 30
Toronto 28
Nuremberg 25
Shenyang 25
Atlanta 24
Brooklyn 24
Johannesburg 24
Pune 24
Tianjin 23
Chennai 22
Fremont 22
Altamura 21
San Diego 21
Stockholm 20
Montreal 19
Andover 18
Changsha 18
Falls Church 18
Phoenix 18
Poplar 18
Biên Hòa 17
Carate Brianza 17
Jinan 17
Zhengzhou 17
Belo Horizonte 16
Lappeenranta 16
Norwalk 16
San Jose 16
Columbus 15
Da Nang 15
Jiaxing 15
Rio de Janeiro 15
Edmonton 14
Hebei 14
Quito 14
Ankara 13
Boston 13
Brasília 13
Hangzhou 13
Manchester 13
Mexico City 13
Monza 13
Turku 13
Brno 12
Como 12
Haiphong 12
Istanbul 12
Ningbo 12
Kunming 11
Totale 11.812
Nome #
Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease 494
QT interval and dispersion in drug-free anorexia nervosa adolescents: a case control study 443
QTc dispersion and interval changes in drug-free borderline personality disorder adolescents 436
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease 400
Irisin and BDNF serum levels and behavioral disturbances in Alzheimer’s disease 392
Serum naturally occurring anti-TDP-43 auto-antibodies are increased in amyotrophic lateral sclerosis 380
Decreased whole-blood global DNA methylation is related to serum hormones in anorexia nervosa adolescents. 378
Paradoxical Increase of plasma vitamin B12 and folates with disease severity in anorexia nervosa 372
THE TOXICITY OF AMYLOID-BETA OLIGOMERS AND TAU HYPERPHOSPHORYLATION ARE PREVENTED FROM LIPID-BASED NANOPARTICLES IN HUMAN PRIMARY FIBOBLASTS 372
Serum DBI and biomarkers of neuroinflammation in Alzheimer's disease and delirium 354
Anorexia nervosa in adolescent girls and celiac disease serology 350
Can Signaling Molecules in Fibroblasts Detect Prodromal Alzheimer's Disease? 349
The one-carbon metabolism in anorexia nervosa of the restrictive type 332
Lipid-based nanoparticles counteract the oligomer abeta toxicity and tau phosphorylation in an ex-vivo biomolecular model of alzheimer disease 330
Donepezil modulates the endogenous immune response: implications for Alzheimer's disease 323
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 323
Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8) 321
Post-methionine load test: A more sensitive tool to reveal hyperhomocysteinemia in Alzheimer patients? 311
Diazepam binding inhibitor and dehydroepiandrosterone sulphate plasma levels in borderline personality disorder adolescents. 299
Beta-amyloid-induced peripheral chemotactic response: what role in Alzheimer’s disease? 296
Behavioural anomalies in neurodegenerative diseases: role of the immune response 295
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 290
Stavudine Reduces NLRP3 Inflammasome Activation and Modulates Amyloid-β Autophagy 288
Valproate induces epigenetic modifications in lymphomonocytes from epileptic patients 281
Riluzole display glutamate-independent antioxidant properties: relevance for ALS 262
Reduced fasting plasma levels of diazepam-binding inhibitor in adolescents with anorexia nervosa 253
Increased Soluble APPalpha, Abeta 1-42, and Anti-Abeta 1-42 Antibodies in Plasma From Down Syndrome Patients 249
Modulation of mapk phosphorylation in fibroblasts from alzheimer patients: erk involvment in glutamate transport and tau hyperphosporylation 248
Anorexia nervosa of the restrictive type and celiac disease in adolescence 247
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis 245
Clinical applicability of pCASL as a substitute for FDG-PET in the etiological diagnosis of MCI and SCD: CAPE study protocol 244
TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease 244
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 243
Cholinesterase inhibitor use is associated with increased plasma levels of anti-Aβ 1-42 antibodies in Alzheimer's disease patients 238
Beta-amyloid plasma levels in adolescents with anorexia nervosa of the restrictive type 237
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores 235
New insights into the genetic etiology of Alzheimer's disease and related dementias 235
Lipid-based nanoparticles as a potential tool to deplete abeta. Toward new therapeutic strategies for Alzheimer’s disease? 231
MAPK phosphorylation in fibroblasts from Alzheimer's disease patients: ERK involvement in EAAT1 expression and modulation with disease severity 228
Modulation of mapk phosphorylation in fibroblasts from alzheimer’s patients: the erk involvment in ad severity and eaat1 expression 226
Lipid-based nanoparticles as a potential tool to reduce abeta toxic effect in a human cellular model 224
THE TOXIC EFFECT OF ABETA OLIGOMERS MAY BE REDUCED BY LIPID-BASED NANOPARTICLES IN HUMAN EX-VIVO MODELS 224
Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report 219
BDNF serum levels with respect to multidimensional assessment in amyotrophic lateral sclerosis 214
Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer's disease 211
the MonzALS collaborative network 210
Blood-based biomarkers of neuroinflammation in alzheimer’s disease: A central role for periphery? 210
Erk signalling modulates app metabolism, tau phosphorylation and eaat1 processing in fibroblasts from alzheimer’s patients 208
Anti-Abeta autoantibodies in cerebral amyloid angiopathy related inflammation: a role for pathogenesis? 207
Longitudinal effects on plasma abeta levels of imatinib, a gamma-secretase activating protein inhibitor 206
CLEARANCE OF BETA-AMYLOID OLIGOMERS BY PERIPHERAL MONOCYTES: FURTHER OBSERVATIONS REGARDING THE MODULATORY ROLE OF DONEPEZIL 206
Binding of lipid-based nanoparticles to plasma abeta: relevance for new therapeutic strategies in Alzheimer’s disease 198
Affective states and pathology in adolescents with borderline personality 195
Myocyte enhancer factor-2D expression in ALS lymphomonocytes 194
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 189
Behavioural Anomalies in Neurodegenerative Diseases: Role of the Immune Response 183
Plasma anti-amyloid-β autoantibodies in all Alzheimer disease types 179
Role of donepezil in influencing endogenous immune response against abeta, an ex vivo and in vitro study 179
Core blood biomarkers of Alzheimer's disease: A single-center real-world performance study 172
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 171
Acetyl-Cholinesterase Inhibitors Modulate The Autoimmune Response Against Beta-Amyloid 159
Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation 158
Novel therapeutic targets in neuropsychiatric disorders: the neuroepigenome 158
Serum BDNF in amyotrophic lateral sclerosis decreases with disease severity 158
Immune response against beta-amyloid is modulated by acetyl-cholinesterase inhibitors 152
Modulation of MAPK- and PI3/AKT-Dependent Autophagy Signaling by Stavudine (D4T) in PBMC of Alzheimer’s Disease Patients 150
Donepezil modulates the endogenous immune response in Alzheimer’s disease, an ex vivo and in vitro study 148
Predictors of response to acetylcholinesterase inhibitors in dementia: A systematic review 147
Whole-blood global DNA methylation and phenotypic variability in ALS 147
Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion 144
Further ex vivo evidence for a role of donepezil in the modulation of the immune response 138
Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data 133
Nilotinib or Dasatinib, but not Imatinib, might reduce Plasma Beta-Amyloid in Leukemia Patients : Implications gor Alzheimer’s Disease 133
Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset 132
ALS genocopy due to co-existence of spastin mutation and SMN2 deletion? A 12 months open label trial with valproic acid 128
Iatrogenic Cerebral Amyloid Angiopathy-Related Inflammation: A Multicenter Case Series 28
Totale 18.486
Categoria #
all - tutte 56.416
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.416


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.123 0 0 0 0 0 162 201 148 166 178 102 166
2021/20221.111 139 145 124 110 71 67 55 50 48 61 85 156
2022/20231.924 192 525 218 207 131 281 36 108 129 25 44 28
2023/20241.311 62 60 71 66 161 323 233 46 59 23 18 189
2024/20253.070 171 277 212 113 238 166 207 141 304 477 263 501
2025/20264.613 1.058 474 665 850 1.123 443 0 0 0 0 0 0
Totale 18.486